components_HeaderAdBanner__0

Pfizer base_Aktie PFE

components_StockPageHeaderMobile__3

0
components_StockPageHeader__1
-0
components_StockPageHeader__2
-0 %

pages_aktie_[isin]__3

Loading chart...
components_charts_QuoteChart_1
components_charts_QuoteChart_18

Pfizer components_charts_QuoteChart_20

components_charts_QuoteChart_19Pfizer components_charts_QuoteChart_3
9/10/20250 undefined
8/10/202525,73 undefined
8/10/202525,70 undefined
7/10/202526,28 undefined
6/10/202526,46 undefined
3/10/202527,34 undefined
3/10/202527,37 undefined
2/10/202527,09 undefined
1/10/202527,11 undefined
29/9/202525,48 undefined
28/9/202523,85 undefined
25/9/202523,76 undefined
24/9/202523,60 undefined
24/9/202524,09 undefined
24/9/202524,08 undefined
23/9/202524,13 undefined
22/9/202524,15 undefined
19/9/202524,05 undefined
19/9/202524,03 undefined
18/9/202524,18 undefined
17/9/202524,10 undefined
16/9/202523,93 undefined
15/9/202523,98 undefined
12/9/202523,96 undefined
12/9/202523,96 undefined
11/9/202524,84 undefined
10/9/202524,56 undefined
9/9/202524,70 undefined

components_charts_RevenueChart_0

  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_RevenueChart_8
components_charts_RevenueChart_10
components_charts_RevenueChart_9
Details
components_charts_RevenueChart_13

Pfizer components_charts_RevenueChart_15

components_charts_RevenueChart_14Pfizer components_charts_RevenueChart_8Pfizer components_charts_RevenueChart_10Pfizer components_charts_RevenueChart_9
2030e55,30 number_format_mrd undefined0 undefined14,13 number_format_mrd undefined
2029e54,90 number_format_mrd undefined18,07 number_format_mrd undefined13,90 number_format_mrd undefined
2028e58,15 number_format_mrd undefined20,00 number_format_mrd undefined15,69 number_format_mrd undefined
2027e62,05 number_format_mrd undefined22,21 number_format_mrd undefined17,99 number_format_mrd undefined
2026e63,45 number_format_mrd undefined22,82 number_format_mrd undefined18,29 number_format_mrd undefined
2025e63,87 number_format_mrd undefined21,87 number_format_mrd undefined17,84 number_format_mrd undefined
202463,63 number_format_mrd undefined16,73 number_format_mrd undefined8,03 number_format_mrd undefined
202359,55 number_format_mrd undefined13,10 number_format_mrd undefined2,12 number_format_mrd undefined
2022101,18 number_format_mrd undefined40,79 number_format_mrd undefined31,37 number_format_mrd undefined
202181,29 number_format_mrd undefined27,54 number_format_mrd undefined21,98 number_format_mrd undefined
202041,65 number_format_mrd undefined10,15 number_format_mrd undefined9,16 number_format_mrd undefined
201941,17 number_format_mrd undefined9,20 number_format_mrd undefined16,27 number_format_mrd undefined
201840,83 number_format_mrd undefined8,48 number_format_mrd undefined11,15 number_format_mrd undefined
201752,55 number_format_mrd undefined15,58 number_format_mrd undefined21,31 number_format_mrd undefined
201652,82 number_format_mrd undefined15,06 number_format_mrd undefined7,21 number_format_mrd undefined
201548,85 number_format_mrd undefined13,63 number_format_mrd undefined6,96 number_format_mrd undefined
201449,61 number_format_mrd undefined14,66 number_format_mrd undefined9,13 number_format_mrd undefined
201351,58 number_format_mrd undefined17,02 number_format_mrd undefined22,00 number_format_mrd undefined
201254,66 number_format_mrd undefined17,32 number_format_mrd undefined14,57 number_format_mrd undefined
201161,04 number_format_mrd undefined18,76 number_format_mrd undefined10,01 number_format_mrd undefined
201065,17 number_format_mrd undefined17,54 number_format_mrd undefined8,26 number_format_mrd undefined
200949,27 number_format_mrd undefined15,89 number_format_mrd undefined8,63 number_format_mrd undefined
200848,30 number_format_mrd undefined16,52 number_format_mrd undefined8,10 number_format_mrd undefined
200748,42 number_format_mrd undefined10,86 number_format_mrd undefined8,14 number_format_mrd undefined
200648,37 number_format_mrd undefined15,01 number_format_mrd undefined19,33 number_format_mrd undefined
200547,41 number_format_mrd undefined14,53 number_format_mrd undefined8,08 number_format_mrd undefined

Pfizer components_StockTable__14

  • components_StockTable_20

  • components_StockTable_21

  • components_StockTable_17

  • components_StockTable_18

  • components_StockTable_19

 
components_StockDataTable_IncomeStatement_0
components_StockTable__1
components_StockTable__2
components_StockDataTable_IncomeStatement_3
components_StockDataTable_IncomeStatement_17
components_StockTable__6
components_StockTable__8
components_StockTable__10
components_StockTable__11
components_StockTable__12
1983198419851986198719881989199019911992199319941995199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025e2026e2027e2028e2029e2030e
3,763,884,024,484,925,395,6711,0912,0112,8313,2714,3917,0618,5419,1323,2327,1726,0529,0232,2944,7448,9947,4148,3748,4248,3049,2765,1761,0454,6651,5849,6148,8552,8252,5540,8341,1741,6581,29101,1859,5563,6363,8763,4562,0558,1554,9055,30
-2,953,8511,239,909,475,3195,618,266,813,488,4518,548,643,1721,4716,94-4,1311,4411,2738,539,50-3,232,040,10-0,252,0132,26-6,34-10,45-5,62-3,84-1,528,13-0,53-22,310,851,1695,1624,46-41,146,840,39-0,67-2,21-6,28-5,580,72
58,8760,5761,5861,5561,4462,4963,6465,9768,1370,0772,2173,0773,0975,6077,7378,8879,4785,5886,8387,5778,5786,9584,7484,2176,7984,7582,9978,1080,8382,0381,6480,8080,4077,4379,3778,2780,4679,8262,2566,3070,1374,3374,0474,5476,2381,3486,1485,52
2,222,352,482,763,023,373,617,328,188,999,5810,5212,4714,0114,8718,3221,5922,2925,2028,2835,1542,6040,1740,7337,1840,9340,8950,9049,3444,8442,1140,0839,2840,9041,7131,9533,1333,2550,6067,0841,7747,30000000
0,460,520,590,670,700,800,691,290,761,450,991,992,312,722,884,634,953,737,799,133,9111,358,0819,338,148,108,638,2610,0114,5722,009,136,967,2121,3111,1516,279,1621,9831,372,128,0317,8418,2917,9915,6913,9014,13
-13,8513,1313,484,5114,53-13,9488,32-41,3291,81-31,96101,6216,1617,336,0860,876,89-24,76109,0217,18-57,20190,66-28,84139,29-57,89-0,486,57-4,3821,2245,5851,02-58,48-23,813,66195,36-47,6645,91-43,71139,9742,74-93,25279,00122,182,48-1,62-12,80-11,371,63
----------------------0,811,011,191,280,660,740,820,900,981,061,141,221,301,381,461,531,571,612,061,691,721,471,361,201,081,08
0000000000000000000000024,6917,827,56-48,4412,1210,819,768,898,167,557,026,566,155,804,792,612,5527,95-17,961,78-14,53-7,48-11,76-10,000
4,074,084,104,114,104,074,086,266,296,266,075,956,016,116,306,366,326,376,366,247,297,617,417,276,946,757,058,077,877,516,906,426,266,166,065,985,685,635,715,735,715,70000000
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
components_StockTable__16
 
components_StockDataTable_BalanceSheet_0
components_StockDataTable_BalanceSheet_1
components_StockDataTable_BalanceSheet_2
components_StockDataTable_BalanceSheet_4
components_StockDataTable_BalanceSheet_5
components_StockDataTable_BalanceSheet_30
components_StockDataTable_BalanceSheet_7
components_StockDataTable_BalanceSheet_8
components_StockDataTable_BalanceSheet_10
components_StockDataTable_BalanceSheet_31
components_StockDataTable_BalanceSheet_32
components_StockDataTable_BalanceSheet_13
components_StockDataTable_BalanceSheet_33
components_StockDataTable_BalanceSheet_15
components_StockDataTable_BalanceSheet_16
components_StockDataTable_BalanceSheet_17
components_StockDataTable_BalanceSheet_18
components_StockDataTable_BalanceSheet_19
components_StockDataTable_BalanceSheet_20
components_StockDataTable_BalanceSheet_34
components_StockDataTable_BalanceSheet_35
components_StockDataTable_BalanceSheet_23
components_StockDataTable_BalanceSheet_24
components_StockDataTable_BalanceSheet_25
components_StockDataTable_BalanceSheet_36
components_StockDataTable_BalanceSheet_37
components_StockDataTable_BalanceSheet_38
components_StockDataTable_BalanceSheet_39
components_StockDataTable_BalanceSheet_41
components_StockDataTable_BalanceSheet_42
components_StockDataTable_BalanceSheet_44
components_StockDataTable_BalanceSheet_46
components_StockDataTable_BalanceSheet_47
components_StockDataTable_BalanceSheet_48
198319841985198619871988198919901991199219931994199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024
                                                                                   
0,720,890,941,011,711,661,891,962,443,042,072,852,362,482,465,076,667,008,8812,9512,3420,5522,7428,2326,0924,5627,1628,4826,4532,4032,4136,1223,2917,8519,9918,839,6512,2231,0722,7312,6920,48
0,770,690,820,981,131,121,232,012,062,152,362,763,263,223,384,605,375,494,805,798,649,379,109,399,848,9614,6513,3813,0610,689,368,408,188,238,228,036,777,9311,4810,9511,1811,46
0000000000000000000000000000000000000003,583,983,31
0,730,740,800,891,031,091,081,561,591,491,571,902,031,882,202,822,592,702,492,685,706,665,486,115,304,3812,408,286,616,086,175,667,516,787,587,517,078,059,068,9810,1910,85
0,120,140,130,090,180,180,300,470,570,870,950,801,272,382,691,701,701,993,053,374,002,529,523,935,615,187,4610,8814,7015,688,315,414,836,095,3515,569,326,878,095,025,304,25
2,352,452,702,964,054,054,505,996,667,566,958,308,939,9610,7414,1816,3117,1919,2124,7830,6839,0946,8447,6646,8543,0861,6761,0160,8264,8356,2455,6043,8038,9541,1449,9332,8035,0759,6951,2643,3350,36
1,161,161,271,351,511,661,783,413,733,814,234,925,485,626,227,248,699,439,7810,7118,1618,3916,2316,6315,7313,2922,7818,6515,9213,2112,4011,7613,7713,3213,8713,3914,2615,2917,7219,2821,8620,68
0,210,180,280,510,731,041,101,661,590,841,281,621,461,941,922,481,762,535,725,166,143,872,503,894,8611,4813,129,759,8114,1516,4117,5216,007,127,022,7720,1520,2621,5315,0715,372,23
000000000000000000000000000000000000004,273,5800
0,110,120,1200000,160,160,160,310,380,411,461,711,73000,760,9235,5933,2526,2424,3520,5017,7268,0257,5651,1845,1539,3935,1740,3652,6548,7435,2133,9428,4725,1543,3764,9055,41
0000,180,190,420,430,500,380,370,230,331,241,050,990,811,871,791,691,2022,2723,7620,9920,8821,3821,4642,3843,9344,5743,6642,5242,0748,2454,4555,9553,4148,2049,5849,2151,3867,7868,53
0,130,150,130,220,400,430,500,590,720,931,151,081,321,421,441,392,742,581,993,583,944,734,182,145,954,124,994,135,704,805,155,465,215,145,084,7218,255,568,1816,8613,2516,19
1,601,611,792,262,823,543,826,326,596,117,218,339,9011,4912,2813,6415,0616,3219,9421,5886,1083,9970,1467,8968,4268,07151,28134,00127,19120,97115,86111,97123,58132,67130,66109,50134,79119,16126,05149,52183,17163,04
3,954,074,495,236,877,598,3212,3113,2413,6714,1616,6318,8321,4523,0227,8231,3733,5139,1546,36116,78123,08116,97115,55115,27111,15212,95195,01188,00185,80172,10167,57167,38171,62171,80159,42167,59154,23185,74200,78226,50213,40
                                                                                   
0,020,020,020,020,020,020,020,190,190,190,190,190,190,390,391,170,330,340,340,340,650,630,610,580,540,520,500,500,490,490,490,480,490,490,490,490,490,470,470,480,480,48
0,460,490,480,490,460,440,380,390,310,490,610,801,451,823,466,035,948,909,309,3766,4067,1067,7669,1069,9170,2870,5070,7671,4272,6177,2878,9881,0282,6984,2886,2587,4388,6790,5991,8092,6393,60
1,852,202,542,933,333,704,116,616,697,387,538,609,9011,4513,2415,4818,4619,6024,4330,2429,3835,4937,6149,6749,6649,1440,4342,7246,2154,2469,7372,1871,9971,7785,2989,5597,6796,77103,39125,66118,35116,73
-0,13-0,21-0,11-0,020,130,150,050,170,03-0,12-0,88-0,73-1,22-1,58-3,17-4,83-3,93-4,90-4,40-3,66-1,701,05-0,44-1,261,75-4,990,22-3,45-4,18-6,19-3,42-7,09-9,30-10,91-9,72-11,21-11,60-11,80-5,68-8,53-7,95-7,74
000000000000000000000000000046,00236,00150,00-222,00-227,00-131,00401,00-68,00-35,00116,00-220,00220,00-9,00-106,00
2,192,502,933,423,934,304,547,367,227,957,458,8610,3312,0813,9317,8420,8023,9329,6736,2994,73104,27105,53118,10121,86114,95111,65110,53113,99121,38144,23144,32143,97143,91160,73165,02173,95174,23188,56209,63203,50202,97
0,240,220,270,310,360,360,400,780,800,860,911,041,241,401,692,491,891,721,411,622,592,672,072,022,271,754,373,993,682,923,233,213,624,544,664,673,894,315,586,816,715,63
0,120,130,140,150,210,210,240,700,460,491,171,171,261,170,640,850,910,981,031,083,141,941,601,901,971,672,242,082,121,881,791,842,362,492,202,402,663,383,784,033,304,19
0,450,440,370,440,620,760,751,011,591,781,561,822,182,052,584,113,804,995,037,189,3610,5813,1415,7411,7714,2725,1416,9619,1017,9712,3111,4013,2613,4013,6215,9614,5615,5331,0728,3627,4326,22
0000000000000000005,908,418,8211,2711,591,724,808,385,442,104,013,983,972,136,446,466,414,0614,730,700,610,408,103,20
0,320,300,210,330,710,971,531,731,821,421,833,152,932,782,622,995,304,290,370,260000,711,020,940,033,500,012,452,063,013,724,233,554,781,462,001,642,552,253,75
1,131,090,991,231,912,302,914,224,674,555,467,187,617,407,5310,4411,9011,9813,7318,5623,9126,4628,4022,1021,8427,0137,2328,6428,9129,1923,3721,5929,4031,1230,4331,8637,3025,9242,6742,1447,7943,00
0,490,340,320,290,250,230,190,500,851,141,121,141,472,402,561,791,771,122,613,145,767,286,355,557,317,9643,1938,4134,9331,0430,4631,5428,7431,4033,5432,9135,9637,1336,2032,8861,5457,41
0,070,070,170,200,320,310,310,180,730,650,880,810,130,1401,330,490,380,400,3613,0112,039,718,027,702,9617,8418,6318,8621,1925,5923,3226,8830,753,903,705,654,060,351,020,642,12
0,040,040,050,070,490,430,350,920,791,081,451,371,871,972,171,583,273,954,124,358,729,046,758,4513,3015,4824,2521,0822,6922,7116,0619,5017,3718,5132,2827,2025,2423,6424,8025,2427,2422,38
0,600,450,540,561,060,970,851,602,372,873,443,313,474,524,724,705,535,457,137,8527,4928,3422,8022,0228,3126,4085,2878,1176,4774,9372,1274,3672,9880,6669,7163,8166,8464,8461,3459,1589,4281,90
1,731,541,531,792,973,273,765,827,047,428,9010,4911,0811,9112,2515,1317,4217,4320,8626,4151,4054,8051,2144,1150,1453,41122,50106,75105,38104,1295,4895,94102,38111,78100,1495,66104,1590,76104,01101,29137,21124,90
3,924,034,465,216,907,578,3113,1814,2615,3716,3619,3521,4124,0026,1832,9838,2241,3750,5362,70146,13159,07156,74162,21172,00168,36234,15217,27219,37225,50239,71240,27246,36255,68260,87260,68278,09264,98292,58310,92340,71327,87
components_StockDataTable_BalanceSheet_49
 
components_StockDataTable_CashflowStatement_0
components_StockDataTable_CashflowStatement_9
components_StockDataTable_CashflowStatement_2
components_StockDataTable_CashflowStatement_8
components_StockDataTable_CashflowStatement_4
components_StockDataTable_CashflowStatement_5
components_StockDataTable_CashflowStatement_6
components_StockDataTable_CashflowStatement_10
components_StockDataTable_CashflowStatement_11
components_StockDataTable_CashflowStatement_13
components_StockDataTable_CashflowStatement_15
components_StockDataTable_CashflowStatement_16
components_StockDataTable_CashflowStatement_18
components_StockDataTable_CashflowStatement_20
components_StockDataTable_CashflowStatement_22
components_StockDataTable_CashflowStatement_24
components_StockDataTable_CashflowStatement_25
components_StockDataTable_CashflowStatement_26
components_StockDataTable_CashflowStatement_27
components_StockDataTable_CashflowStatement_28
1987198819891990199119921993199419951996199719981999200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023
0,690,790,681,290,761,460,991,992,312,552,943,234,973,737,799,133,9111,368,0919,348,198,138,648,2910,0514,6022,079,176,997,2521,3611,1916,309,6522,0331,412,16
0,170,200,210,350,380,420,430,470,580,590,710,800,910,880,971,034,035,095,585,295,205,094,768,409,037,666,415,545,165,766,276,386,014,785,195,066,29
0000,03-0,120,01-0,470,080,080,150,02-0,160,21-0,210,19-0,29-0,10-1,58-1,38-1,53-2,79-1,33-9,582,110,240,791,730,32-0,02-0,70-2,41-2,210,61-1,47-4,29-3,76-3,44
0,460,00-0,22-0,15-0,30-0,54-0,46-0,50-0,44-0,06-0,520,95-0,911,850,350,31-1,28-0,86-0,582,60-0,804,8612,52-10,362,53-2,37-3,381,630,740,101,34-0,93-4,03-0,2812,80-4,46-2,17
-0,03-0,11-0,01-0,120,870,111,240,090,09-0,250,120,360,29-0,14-0,13-0,005,182,333,03-8,113,561,880,603,43-1,19-3,45-8,621,022,494,48-8,912,31-5,622,47-1,971,896,39
0,070,090,12000000000,260,380,460,290,260,350,500,650,720,640,780,942,162,091,871,731,551,301,451,521,311,591,641,471,442,22
0,220,270,24000000001,361,571,040,961,482,913,394,713,445,622,252,3011,782,932,412,872,102,382,522,493,663,663,157,437,873,15
1,290,870,661,391,581,451,732,132,622,993,285,185,476,109,1710,1811,7316,3414,7317,5913,3518,2416,5911,4520,2416,7517,6817,0814,6916,1916,8015,8312,5914,4032,5829,278,70
-258,00-344,00-456,00-788,00-920,00-1008,00-981,00-1078,00-1083,00-1079,00-1391,00-2181,00-2746,00-2247,00-2332,00-2286,00-3417,00-2928,00-2537,00-2203,00-1880,00-1701,00-1205,00-1513,00-1882,00-1419,00-1465,00-1583,00-1496,00-1999,00-2217,00-2196,00-2594,00-2791,00-2711,00-3236,00-3907,00
-1,11-0,96-0,63-0,56-0,430,06-0,96-1,54-2,71-1,96-1,62-0,77-3,91-3,64-7,14-4,344,85-9,42-5,075,100,80-12,84-31,27-0,491,846,15-10,54-5,65-2,98-7,79-4,744,53-3,95-4,27-22,55-15,78-32,28
-0,85-0,61-0,170,230,491,060,02-0,46-1,63-0,89-0,231,41-1,16-1,39-4,80-2,058,27-6,49-2,547,302,68-11,13-30,071,023,737,57-9,08-4,07-1,48-5,79-2,526,72-1,35-1,48-19,84-12,55-28,37
0000000000000000000000000000000000000
0,300,270,61-0,020,510,030,371,300,070,850,01-0,492,10-1,713,512,51-0,594,10-0,32-9,934,902,4120,12-4,15-5,54-1,736,040,541,322,61-0,94-0,948,76-12,76-1,10-3,5235,95
-126,00-7,00-155,00-183,00-474,00-665,00-1117,00-510,00-65,00178,00-207,00-1651,00-1906,00183,00-2892,00-4336,00-11.965,00-5647,00-3346,00-6247,00-9535,00-426,00-91,00-934,00-8847,00-7660,00-14.540,00-3998,00-4897,00-3981,00-4138,00-10.939,00-8471,00425,000-2000,000
-0,07-0,060,14-0,74-0,46-1,33-1,54-0,11-0,86-0,18-1,49-3,64-1,63-3,73-2,10-5,00-16,91-6,63-9,22-23,10-12,61-6,5614,48-11,17-20,61-16,00-14,98-10,19-10,41-9,23-13,35-20,44-8,49-9,65-9,82-14,8326,07
0,050,010,040,070,180,070,050,020,15-0,06000000000000000,02-0,080,11-0,120,11-0,54-0,61-0,59-0,7411,120,02-0,34-0,63
-297,00-330,00-364,00-601,00-674,00-762,00-844,00-921,00-1010,00-1145,00-1294,00-1501,00-1820,00-2197,00-2715,00-3168,00-4353,00-5082,00-5555,00-6919,00-7975,00-8541,00-5548,00-6088,00-6234,00-6534,00-6580,00-6609,00-6940,00-7317,00-7659,00-7978,00-8043,00-8440,00-8729,00-8983,00-9247,00
0,13-0,140,160,100,670,13-0,810,51-0,980,840,110,79-0,05-1,26-0,060,84-0,360,290,44-0,421,58-1,28-0,14-0,241,456,90-7,901,160,30-1,04-1,24-0,210,130,480,16-1,522,45
1035,00529,00200,00601,00663,00438,00749,001053,001538,001906,001884,003000,002727,003853,006842,007897,008310,0013.412,0012.196,0015.391,0011.473,0016.537,0015.382,009941,0018.358,0015.327,0016.219,0015.501,0013.191,0014.194,0014.585,0013.631,009993,0011.612,0029.869,0026.031,004793,00
0000000000000000000000000000000000000

components_charts_MarginsChart_0

components_charts_MarginsChart_18
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_MarginsChart_15
components_charts_MarginsChart_17
components_charts_MarginsChart_16
Details
components_charts_MarginsChart_19

Pfizer components_charts_MarginsChart_21

Pfizer components_charts_MarginsChart_15Pfizer components_charts_MarginsChart_16Pfizer components_charts_MarginsChart_17Pfizer components_charts_MarginsChart_16
2030e74,33 %0 %25,55 %
2029e74,33 %32,91 %25,32 %
2028e74,33 %34,39 %26,98 %
2027e74,33 %35,79 %28,99 %
2026e74,33 %35,96 %28,82 %
2025e74,33 %34,24 %27,94 %
202474,33 %26,29 %12,62 %
202370,13 %21,99 %3,56 %
202266,30 %40,31 %31,01 %
202162,25 %33,87 %27,04 %
202079,82 %24,38 %21,99 %
201980,46 %22,34 %39,52 %
201878,27 %20,78 %27,32 %
201779,37 %29,66 %40,55 %
201677,43 %28,51 %13,66 %
201580,40 %27,91 %14,25 %
201480,80 %29,55 %18,41 %
201381,64 %32,99 %42,65 %
201282,03 %31,68 %26,65 %
201180,83 %30,74 %16,40 %
201078,10 %26,92 %12,67 %
200982,99 %32,25 %17,52 %
200884,75 %34,20 %16,77 %
200776,79 %22,43 %16,81 %
200684,21 %31,04 %39,97 %
200584,74 %30,64 %17,04 %

components_charts_RevenuePerShareChart_0

components_charts_RevenuePerShareChart_13
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_RevenuePerShareChart_10
components_charts_RevenuePerShareChart_12
components_charts_RevenuePerShareChart_11
Details
components_charts_RevenuePerShareChart_16

Pfizer components_charts_RevenuePerShareChart_18

components_charts_RevenuePerShareChart_17Pfizer components_charts_RevenuePerShareChart_10Pfizer components_charts_RevenuePerShareChart_12Pfizer components_charts_RevenuePerShareChart_11
2030e9,70 undefined0 undefined2,48 undefined
2029e9,63 undefined0 undefined2,44 undefined
2028e10,20 undefined0 undefined2,75 undefined
2027e10,89 undefined0 undefined3,16 undefined
2026e11,13 undefined0 undefined3,21 undefined
2025e11,21 undefined0 undefined3,13 undefined
202411,16 undefined2,93 undefined1,41 undefined
202310,43 undefined2,29 undefined0,37 undefined
202217,65 undefined7,11 undefined5,47 undefined
202114,24 undefined4,82 undefined3,85 undefined
20207,40 undefined1,80 undefined1,63 undefined
20197,25 undefined1,62 undefined2,87 undefined
20186,83 undefined1,42 undefined1,87 undefined
20178,67 undefined2,57 undefined3,52 undefined
20168,58 undefined2,45 undefined1,17 undefined
20157,81 undefined2,18 undefined1,11 undefined
20147,72 undefined2,28 undefined1,42 undefined
20137,48 undefined2,47 undefined3,19 undefined
20127,28 undefined2,31 undefined1,94 undefined
20117,76 undefined2,38 undefined1,27 undefined
20108,07 undefined2,17 undefined1,02 undefined
20096,99 undefined2,26 undefined1,23 undefined
20087,15 undefined2,45 undefined1,20 undefined
20076,98 undefined1,57 undefined1,17 undefined
20066,65 undefined2,06 undefined2,66 undefined
20056,40 undefined1,96 undefined1,09 undefined

pages_aktie_[isin]__4

pages_aktie_[isin]__5

components_charts_RevenueBreakdownSegmentChart_0

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Padcev52,00 number_format_mio USD--------
BNT162b2---------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Alliance Biopharmaceuticals-7,65 number_format_mrd USD-------
Total Sterile Injectable Pharmaceuticals-5,75 number_format_mrd USD-------
Ibrance-5,44 number_format_mrd USD-------
Prevenar 13/Prevnar 13-5,27 number_format_mrd USD-------
Other Hospital Products-2,41 number_format_mrd USD-------
Total Biosimilars-2,34 number_format_mrd USD-------
Vyndaqel/Vyndamax-2,02 number_format_mrd USD-------
All Other Internal Medicine-1,71 number_format_mrd USD-------
Other Anti-infectives-1,45 number_format_mrd USD-------
Enbrel-1,19 number_format_mrd USD-------
Xtandi Alliance Revenues-1,19 number_format_mrd USD-------
Inlyta-1,00 number_format_mrd USD-------
Abrysvo890,00 number_format_mio USD--------
Celebrex--719,00 number_format_mio USD------
Sulperazon-683,00 number_format_mio USD-------
Sutent-673,00 number_format_mio USD-------
Inflectra/Remsima-657,00 number_format_mio USD-------
Premarin Family-563,00 number_format_mio USD-------
Bosulif-540,00 number_format_mio USD-------
Xalkori-493,00 number_format_mio USD-------
Ruxience-491,00 number_format_mio USD-------
Retacrit-444,00 number_format_mio USD-------
Zirabev-444,00 number_format_mio USD-------
BeneFIX-438,00 number_format_mio USD-------
Medrol-432,00 number_format_mio USD-------
IVIg Products-430,00 number_format_mio USD-------
Zavicefta-413,00 number_format_mio USD-------
Chantix Champix-398,00 number_format_mio USD-------
Genotropin-389,00 number_format_mio USD-------
Mektovi174,00 number_format_mio USD155,00 number_format_mio USD-------
Fragmin-305,00 number_format_mio USD-------
ReFacto AF Xyntha-304,00 number_format_mio USD-------
Zithromax Zmax-278,00 number_format_mio USD-------
Somavert-277,00 number_format_mio USD-------
Vfend-267,00 number_format_mio USD-------
BMP2-266,00 number_format_mio USD-------
Lorbrena-266,00 number_format_mio USD-------
Other Oncology Products-238,00 number_format_mio USD-------
Toviaz-238,00 number_format_mio USD-------
Aromasin-211,00 number_format_mio USD-------
Tygacil-200,00 number_format_mio USD-------
Trazimera-197,00 number_format_mio USD-------
Nimenrix-193,00 number_format_mio USD-------
Besponsa-192,00 number_format_mio USD-------
Braftovi-187,00 number_format_mio USD-------
Pristiq-187,00 number_format_mio USD-------
FSME/IMMUN-TicoVac-185,00 number_format_mio USD-------
Bavencio Alliance Revenues-178,00 number_format_mio USD-------
Precedex-177,00 number_format_mio USD-------
Zyvox-173,00 number_format_mio USD-------
All Other Inflammation and Immunology Products-134,00 number_format_mio USD-------
Trumenba-118,00 number_format_mio USD-------
All Other Rare Disease Products-115,00 number_format_mio USD-------
Paxlovid-76,00 number_format_mio USD-------
Other Vaccines Products-74,00 number_format_mio USD-------
Panzyga---------
Pfizer CentreOne---------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Prevenar 13/Prevnar 13--5,85 number_format_mrd USD------
Total Sterile Injectable Pharmaceuticals--5,04 number_format_mrd USD------
Ibrance--4,96 number_format_mrd USD------
Alliance Biopharmaceuticals--4,65 number_format_mrd USD------
Lyrica--3,32 number_format_mrd USD------
All Other Internal Medicine--2,52 number_format_mrd USD------
Other Hospital Products--2,44 number_format_mrd USD------
Lipitor--1,97 number_format_mrd USD------
Enbrel--1,70 number_format_mrd USD------
All Other Upjohn Products--1,52 number_format_mrd USD------
Paxlovid1,28 number_format_mrd USD--------
Other Anti-infectives--1,11 number_format_mrd USD------
Chantix Champix--1,11 number_format_mrd USD------
Norvasc--950,00 number_format_mio USD------
Sutent--936,00 number_format_mio USD------
Total Biosimilars--911,00 number_format_mio USD------
Xtandi Alliance Revenues--838,00 number_format_mio USD------
Pfizer CentreOne--810,00 number_format_mio USD------
Premarin Family--734,00 number_format_mio USD------
Sulperazon--684,00 number_format_mio USD------
Inflectra/Remsima--625,00 number_format_mio USD------
Other Oncology Products--585,00 number_format_mio USD------
Xalkori--530,00 number_format_mio USD------
Genotropin--498,00 number_format_mio USD------
Viagra--497,00 number_format_mio USD------
BeneFIX--488,00 number_format_mio USD------
Inlyta--477,00 number_format_mio USD------
Vyndaqel/Vyndamax--473,00 number_format_mio USD------
Medrol--469,00 number_format_mio USD------
ReFacto AF Xyntha--426,00 number_format_mio USD------
Vfend--346,00 number_format_mio USD------
Effexor--336,00 number_format_mio USD------
Zithromax Zmax--336,00 number_format_mio USD------
Zoloft--294,00 number_format_mio USD------
BMP2--287,00 number_format_mio USD------
Xalatan Xalacom--281,00 number_format_mio USD------
Somavert--264,00 number_format_mio USD------
Fragmin--253,00 number_format_mio USD------
Zyvox--251,00 number_format_mio USD------
Toviaz--250,00 number_format_mio USD------
Nimenrix--230,00 number_format_mio USD------
Retacrit--225,00 number_format_mio USD------
FSME/IMMUN-TicoVac--220,00 number_format_mio USD------
Zosyn / Tazocin--200,00 number_format_mio USD------
Xanax--198,00 number_format_mio USD------
Tygacil--197,00 number_format_mio USD------
Diflucan--190,00 number_format_mio USD------
Panzyga--183,00 number_format_mio USD------
Revatio--144,00 number_format_mio USD------
Trumenba--135,00 number_format_mio USD------
All Other Rare Disease Products--129,00 number_format_mio USD------
Other Vaccines Products--73,00 number_format_mio USD------
Mektovi--49,00 number_format_mio USD------
Braftovi--48,00 number_format_mio USD------
All Other Inflammation and Immunology Products--29,00 number_format_mio USD------
HIS Products---------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Comirnaty Direct Sales and Alliance Revenues11,22 number_format_mrd USD--------
Eliquis Alliance Revenues and Direct Sales6,75 number_format_mrd USD--------
Prevnar Family6,44 number_format_mrd USD--------
Lyrica---4,97 number_format_mrd USD-----
Ibrance4,75 number_format_mrd USD--------
Alliance Biopharmaceuticals---3,84 number_format_mrd USD-----
Vyndaqel Family3,32 number_format_mrd USD--------
All other Specialty Care2,24 number_format_mrd USD--------
All other Primary Care1,78 number_format_mrd USD--------
Xeljanz1,70 number_format_mrd USD--------
Pfizer CentreOne1,27 number_format_mrd USD--------
Xtandi Alliance Revenues1,19 number_format_mrd USD--------
All other Anti-infectives1,09 number_format_mrd USD--------
Inlyta1,04 number_format_mrd USD--------
Nurtec ODT/Vydura928,00 number_format_mio USD--------
Enbrel (Outside the U.S. and Canada)830,00 number_format_mio USD--------
Sulperazon757,00 number_format_mio USD--------
Bosulif645,00 number_format_mio USD--------
Viagra---636,00 number_format_mio USD-----
Ig Portfolio584,00 number_format_mio USD--------
Genotropin539,00 number_format_mio USD--------
Lorbrena539,00 number_format_mio USD--------
Zavicefta511,00 number_format_mio USD--------
Inflectra490,00 number_format_mio USD--------
All other Oncology433,00 number_format_mio USD--------
BeneFIX424,00 number_format_mio USD--------
Zirabev424,00 number_format_mio USD--------
Zithromax406,00 number_format_mio USD--------
Premarin Family397,00 number_format_mio USD--------
Ruxience390,00 number_format_mio USD--------
Xalkori374,00 number_format_mio USD--------
Retacrit340,00 number_format_mio USD--------
Medrol339,00 number_format_mio USD--------
BMP2338,00 number_format_mio USD--------
Oxbryta328,00 number_format_mio USD--------
Aromasin301,00 number_format_mio USD--------
FSME-IMMUN/TicoVac268,00 number_format_mio USD--------
Somavert267,00 number_format_mio USD--------
Fragmin238,00 number_format_mio USD--------
Besponsa236,00 number_format_mio USD--------
ReFacto AF/Xyntha230,00 number_format_mio USD--------
Braftovi213,00 number_format_mio USD--------
Cresemba195,00 number_format_mio USD--------
Bavencio Alliance Revenues190,00 number_format_mio USD--------
Vfend187,00 number_format_mio USD--------
Sutent180,00 number_format_mio USD--------
Nimenrix179,00 number_format_mio USD--------
Bicillin158,00 number_format_mio USD--------
Cibinqo128,00 number_format_mio USD--------
Trumenba126,00 number_format_mio USD--------
Trazimera91,00 number_format_mio USD--------
Adcetris46,00 number_format_mio USD--------
Pfizer Ignite44,00 number_format_mio USD--------
Tukysa17,00 number_format_mio USD--------
Tivdak4,00 number_format_mio USD--------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Co-promotion-7,65 number_format_mrd USD-------
Product-590,00 number_format_mio USD-------
Epi Pen--303,00 number_format_mio USD------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Comirnaty direct sales and alliance revenues-36,78 number_format_mrd USD-------
Bosulif--365,00 number_format_mio USD------
Eliquis---------
Xeljanz---------
  • chart_toolbar_3y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Eliquis-5,97 number_format_mrd USD-------
Xeljanz-2,46 number_format_mrd USD-------
Epi Pen---------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Biopharmaceutical-------45,71 number_format_mrd USD3,66 number_format_mrd USD
Prevenar Family----5,60 number_format_mrd USD5,72 number_format_mrd USD6,25 number_format_mrd USD4,46 number_format_mrd USD-
Lyrica----4,51 number_format_mrd USD4,97 number_format_mrd USD3,66 number_format_mrd USD5,17 number_format_mrd USD-
Other Legacy Established Products----5,08 number_format_mrd USD4,54 number_format_mrd USD4,57 number_format_mrd USD--
Enbrel----2,45 number_format_mrd USD2,91 number_format_mrd USD3,33 number_format_mrd USD3,85 number_format_mrd USD-
All Other Sterile Injectable Pharmaceuticals----3,72 number_format_mrd USD4,58 number_format_mrd USD2,56 number_format_mrd USD--
Lipitor----1,92 number_format_mrd USD1,76 number_format_mrd USD1,86 number_format_mrd USD2,06 number_format_mrd USD-
Consumer Healthcare------3,40 number_format_mrd USD3,45 number_format_mrd USD-
Alliance Biopharmaceuticals----2,93 number_format_mrd USD1,59 number_format_mrd USD1,31 number_format_mrd USD957,00 number_format_mio USD-
Other Biopharmaceuticals------405,00 number_format_mio USD6,18 number_format_mrd USD-
Ibrance----3,13 number_format_mrd USD2,14 number_format_mrd USD723,00 number_format_mio USD--
Celebrex----775,00 number_format_mio USD733,00 number_format_mio USD830,00 number_format_mio USD2,70 number_format_mrd USD-
Sutent----1,08 number_format_mrd USD1,10 number_format_mrd USD1,12 number_format_mrd USD1,17 number_format_mrd USD-
Premarin Family----977,00 number_format_mio USD1,02 number_format_mrd USD1,02 number_format_mrd USD1,08 number_format_mrd USD-
Norvasc----926,00 number_format_mio USD962,00 number_format_mio USD991,00 number_format_mio USD1,11 number_format_mrd USD-
Viagra----382,00 number_format_mio USD1,18 number_format_mrd USD411,00 number_format_mio USD1,69 number_format_mrd USD-
Chantix Champix----997,00 number_format_mio USD842,00 number_format_mio USD671,00 number_format_mio USD647,00 number_format_mio USD-
Xeljanz----1,35 number_format_mrd USD927,00 number_format_mio USD523,00 number_format_mio USD308,00 number_format_mio USD-
Zyvox----281,00 number_format_mio USD421,00 number_format_mio USD883,00 number_format_mio USD1,35 number_format_mrd USD-
BeneFIX----604,00 number_format_mio USD712,00 number_format_mio USD752,00 number_format_mio USD856,00 number_format_mio USD-
Eliquis----2,52 number_format_mrd USD----
Pristiq----303,00 number_format_mio USD732,00 number_format_mio USD715,00 number_format_mio USD737,00 number_format_mio USD-
Genotropin----532,00 number_format_mio USD579,00 number_format_mio USD617,00 number_format_mio USD723,00 number_format_mio USD-
Vfend----421,00 number_format_mio USD590,00 number_format_mio USD682,00 number_format_mio USD756,00 number_format_mio USD-
ReFacto AF Xyntha----551,00 number_format_mio USD554,00 number_format_mio USD533,00 number_format_mio USD631,00 number_format_mio USD-
Xalkori----594,00 number_format_mio USD561,00 number_format_mio USD488,00 number_format_mio USD438,00 number_format_mio USD-
Medrol----483,00 number_format_mio USD450,00 number_format_mio USD402,00 number_format_mio USD443,00 number_format_mio USD-
Xalatan Xalacom----335,00 number_format_mio USD363,00 number_format_mio USD399,00 number_format_mio USD495,00 number_format_mio USD-
Inlyta----339,00 number_format_mio USD401,00 number_format_mio USD430,00 number_format_mio USD410,00 number_format_mio USD-
Sulperazon----471,00 number_format_mio USD396,00 number_format_mio USD339,00 number_format_mio USD354,00 number_format_mio USD-
Zoloft----291,00 number_format_mio USD304,00 number_format_mio USD374,00 number_format_mio USD423,00 number_format_mio USD-
Fragmin----306,00 number_format_mio USD318,00 number_format_mio USD335,00 number_format_mio USD364,00 number_format_mio USD-
Relpax----236,00 number_format_mio USD323,00 number_format_mio USD352,00 number_format_mio USD382,00 number_format_mio USD-
Other Products------506,00 number_format_mio USD451,00 number_format_mio USD299,00 number_format_mio USD
Effexor----297,00 number_format_mio USD278,00 number_format_mio USD288,00 number_format_mio USD344,00 number_format_mio USD-
Tygacil----260,00 number_format_mio USD274,00 number_format_mio USD304,00 number_format_mio USD323,00 number_format_mio USD-
Zithromax Zmax----270,00 number_format_mio USD272,00 number_format_mio USD275,00 number_format_mio USD314,00 number_format_mio USD-
Revatio----252,00 number_format_mio USD285,00 number_format_mio USD260,00 number_format_mio USD276,00 number_format_mio USD-
Toviaz----257,00 number_format_mio USD258,00 number_format_mio USD267,00 number_format_mio USD288,00 number_format_mio USD-
Epi Pen----290,00 number_format_mio USD386,00 number_format_mio USD339,00 number_format_mio USD--
BMP2----261,00 number_format_mio USD251,00 number_format_mio USD232,00 number_format_mio USD228,00 number_format_mio USD-
Somavert----254,00 number_format_mio USD232,00 number_format_mio USD218,00 number_format_mio USD229,00 number_format_mio USD-
Xanax/Xanax XR----225,00 number_format_mio USD222,00 number_format_mio USD224,00 number_format_mio USD253,00 number_format_mio USD-
All Other Peri-LOE Products----257,00 number_format_mio USD276,00 number_format_mio USD362,00 number_format_mio USD--
All Other Internal Medicine----312,00 number_format_mio USD573,00 number_format_mio USD---
Xtandi Alliance----590,00 number_format_mio USD140,00 number_format_mio USD---
Rapamune-----170,00 number_format_mio USD197,00 number_format_mio USD339,00 number_format_mio USD-
Cardura-----192,00 number_format_mio USD210,00 number_format_mio USD263,00 number_format_mio USD-
Inflectra/Remsima----419,00 number_format_mio USD192,00 number_format_mio USD---
Neurontin-----182,00 number_format_mio USD196,00 number_format_mio USD210,00 number_format_mio USD-
Diflucan-----119,00 number_format_mio USD181,00 number_format_mio USD220,00 number_format_mio USD-
Other Vaccines Products----266,00 number_format_mio USD239,00 number_format_mio USD---
Depo-Provera-----126,00 number_format_mio USD170,00 number_format_mio USD201,00 number_format_mio USD-
All Other Rare Disease Products----300,00 number_format_mio USD122,00 number_format_mio USD---
FSME-IMMUN/TicoVac----134,00 number_format_mio USD114,00 number_format_mio USD104,00 number_format_mio USD--
Tikosyn-----153,00 number_format_mio USD179,00 number_format_mio USD--
Unasyn------118,00 number_format_mio USD207,00 number_format_mio USD-
Other Oncology Products----93,00 number_format_mio USD231,00 number_format_mio USD---
Zosyn Tazocin-------303,00 number_format_mio USD-
EpiPen-------294,00 number_format_mio USD-
Precedex----243,00 number_format_mio USD----
All Other Biosimilars----112,00 number_format_mio USD127,00 number_format_mio USD---
Bosulif----233,00 number_format_mio USD----
Inspra-------233,00 number_format_mio USD-
Detrol Detrol LA-------201,00 number_format_mio USD-
Protonix / Pantoprazole-------198,00 number_format_mio USD-
All Other Inflammation and Immunology Products----103,00 number_format_mio USD93,00 number_format_mio USD---
Tazosyn / Zosyn----194,00 number_format_mio USD----
Dalacin / Cleocin-------184,00 number_format_mio USD-
Caduet-------180,00 number_format_mio USD-
Eucrisa----67,00 number_format_mio USD----
Sildenafil Citrate----56,00 number_format_mio USD----
Co-promotion---------
Product---------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Eliquis--4,22 number_format_mrd USD------
Xeljanz--2,24 number_format_mrd USD------
Braftovi---------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Co-promotion--4,65 number_format_mrd USD------
Product--664,00 number_format_mio USD------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Eucrisa--138,00 number_format_mio USD------
  • chart_toolbar_3y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Biopharma57,19 number_format_mrd USD79,56 number_format_mrd USD-------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Reportable Segments--------64,99 number_format_mrd USD
Innovative Health Segment----31,42 number_format_mrd USD29,20 number_format_mrd USD---
Operating Segments-------49,15 number_format_mrd USD-
Global Established Pharmaceutical------21,59 number_format_mrd USD25,15 number_format_mrd USD-
Essential Health Segment----21,12 number_format_mrd USD23,63 number_format_mrd USD---
Biopharma Segment--39,42 number_format_mrd USD------
Global Innovative Pharmaceutical------13,95 number_format_mrd USD13,86 number_format_mrd USD-
Global Vaccines, Oncology and Consumer Healthcare------12,80 number_format_mrd USD10,14 number_format_mrd USD-
Primary Care--------22,67 number_format_mrd USD
Established Products and Emerging Markets--------18,51 number_format_mrd USD
Specialty Care And Oncology--------16,57 number_format_mrd USD
Animal Health and Consumer Healthcare--------7,24 number_format_mrd USD
Innovative Health and Essential Health----1,20 number_format_mrd USD4,97 number_format_mrd USD---
Global Innovative and Established Pharmaceutical------1,31 number_format_mrd USD1,69 number_format_mrd USD-
Nutrition and other business activities--------2,44 number_format_mrd USD
Pfizer CentreOne-1,73 number_format_mrd USD-------
Business Innovation Segment1,31 number_format_mrd USD--------
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownSegmentChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

Segmente202320212019201820172016201520142011
Innovative Health and Essential Health---53,65 number_format_mrd USD-----

components_charts_RevenueBreakdownRegionChart_0

  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

Details
components_charts_RevenueBreakdownRegionChart_1

Pfizer components_charts_RevenueBreakdownSegmentChart_0

components_charts_DividendChart_12Developed EuropeDeveloped Rest of WorldDeveloped Rest Of WorldEmerging MarketsUnited StatesUnited States [Member}US
202311,65 number_format_mrd USD7,76 number_format_mrd USD-12,00 number_format_mrd USD27,09 number_format_mrd USD--
202118,34 number_format_mrd USD-12,51 number_format_mrd USD20,70 number_format_mrd USD--29,75 number_format_mrd USD
20207,79 number_format_mrd USD-4,04 number_format_mrd USD8,37 number_format_mrd USD--21,71 number_format_mrd USD
20198,70 number_format_mrd USD-6,47 number_format_mrd USD12,73 number_format_mrd USD23,85 number_format_mrd USD--
20189,12 number_format_mrd USD-6,55 number_format_mrd USD12,65 number_format_mrd USD25,33 number_format_mrd USD--
20176,80 number_format_mrd USD-6,61 number_format_mrd USD11,40 number_format_mrd USD26,03 number_format_mrd USD--
20169,31 number_format_mrd USD-6,73 number_format_mrd USD10,42 number_format_mrd USD-26,37 number_format_mrd USD-
20159,71 number_format_mrd USD-6,30 number_format_mrd USD11,14 number_format_mrd USD-21,70 number_format_mrd USD-
201411,72 number_format_mrd USD-7,31 number_format_mrd USD11,50 number_format_mrd USD19,07 number_format_mrd USD--
201112,00 number_format_mrd USD-11,09 number_format_mrd USD13,10 number_format_mrd USD26,93 number_format_mrd USD--
Eulerpool Premium

components_PaywallOverlay_0

components_HeaderAdBanner_3

pages_aktie_[isin]__6

components_charts_FairValueChart_20

pages_aktie_[isin]__7

Eulerpool Premium

components_PaywallOverlay_0

components_HeaderAdBanner_3

components_charts_SharesOutstandingChart_0

components_charts_SharesOutstandingChart_9
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_SharesOutstandingChart_8
Details
components_charts_RevenuePerShareChart_16

Pfizer components_StockSplitTable__0

components_StockSplitsTable_0

components_charts_DividendChart_7

components_charts_DividendChart_6
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_DividendChart_8
components_charts_DividendChart_9
Details
components_charts_DividendChart_10

Pfizer components_charts_DividendChart_11

components_charts_DividendChart_12Pfizer components_charts_DividendChart_8
2030e1,08 undefined
2029e1,08 undefined
2028e1,20 undefined
2027e1,36 undefined
2026e1,47 undefined
2025e0,86 undefined
2025e0,86 undefined
20241,69 undefined
20232,06 undefined
20221,61 undefined
20211,57 undefined
20201,53 undefined
20191,46 undefined
20181,38 undefined
20171,30 undefined
20161,22 undefined
20151,14 undefined
20141,06 undefined
20130,98 undefined
20120,90 undefined
20110,82 undefined
20100,74 undefined
20090,66 undefined
20081,28 undefined
20071,19 undefined
20061,01 undefined
20050,81 undefined

components_charts_PayoutRatioChart_0

components_charts_PayoutRatioChart_10
  • chart_toolbar_3y

  • chart_toolbar_5y

  • chart_toolbar_10y

  • components_charts_BaseChart_0

  • chart_toolbar_max

components_charts_PayoutRatioChart_9
Details
components_charts_PayoutRatioChart_11

Pfizer components_charts_PayoutRatioChart_13

components_charts_PayoutRatioChart_12Pfizer components_charts_PayoutRatioChart_9
2030e43,58 %
2029e44,16 %
2028e43,56 %
2027e43,02 %
2026e45,90 %
2025e41,74 %
202441,43 %
202354,53 %
202229,25 %
202140,52 %
202093,83 %
201950,35 %
201873,12 %
201745,01 %
2016128,21 %
2015100,90 %
201473,76 %
201330,09 %
201245,36 %
201162,99 %
201069,90 %
200966,12 %
2008107,56 %
200798,31 %
200636,23 %
200569,72 %
Eulerpool Premium

components_PaywallOverlay_0

components_HeaderAdBanner_3
pages_aktie_[isin]__2

Pfizer components_EarningsSuprises__0

components_EarningsSuprises__1components_EarningsSuprises__2components_EarningsSuprises__3components_EarningsSuprises__4
30/6/20250,59 0,78  (32,90 %)2025 Q2
31/3/20250,67 0,92  (37,46 %)2025 Q1
31/12/20240,48 0,63  (32,52 %)2024 Q4
30/9/20240,62 1,06  (69,68 %)2024 Q3
30/6/20240,46 0,60  (30,26 %)2024 Q2
31/3/20240,53 0,82  (55,04 %)2024 Q1
31/12/2023-0,22 0,10  (145,39 %)2023 Q4
30/9/2023-0,34 -0,17  (49,90 %)2023 Q3
30/6/20230,57 0,67  (16,85 %)2023 Q2
31/3/20230,99 1,23  (24,56 %)2023 Q1
1
2
3
4
5
...
12

components_ESGRating_0

Eulerpool World ESG Rating (EESG©)

73/ 100

🌱 Environment

81

👫 Social

87

🏛️ Governance

50

components_ESGRating_1

components_ESGRating_35
620.124
components_ESGRating_36
500.077
components_ESGRating_37
4.338.487
components_ESGRating_38
1.120.201
components_ESGRating_11
components_ESGRating_39
components_ESGRating_47
components_ESGRating_24
components_ESGRating_42
components_ESGRating_49
components_ESGRating_48
components_ESGRating_50
components_ESGRating_44
components_ESGRating_8
components_ESGRating_12
components_ESGRating_13
components_ESGRating_16
components_ESGRating_17
components_ESGRating_18
components_ESGRating_19

components_ESGRating_2

components_ESGRating_2050,2
components_ESGRating_21
components_ESGRating_259
components_ESGRating_2620,3
components_ESGRating_298,4
components_ESGRating_306,9
components_ESGRating_2722,3
components_ESGRating_286,9
components_ESGRating_3156,3
components_ESGRating_3263,4
components_ESGRating_22
components_ESGRating_23
components_ESGRating_51
components_ESGRating_41
components_ESGRating_43
components_ESGRating_46
components_ESGRating_9
components_ESGRating_10
components_ESGRating_15
components_ESGRating_33

components_ESGRating_3

components_ESGRating_40
components_ESGRating_34
components_ESGRating_45
components_ESGRating_14

components_ESGRating_4 components_ESGRating_52 components_ESGRating_5

Pfizer components_CompanyExecutives__0

Dr. Albert Bourla

(63)
Pfizer Chairman of the Board, Chief Executive Officer (components_CompanyExecutives__1 2014)
components_CompanyExecutives__2 24,65 number_format_mio

Mr. Aamir Malik

(49)
Pfizer Executive Vice President, Chief US Commercial Officer
components_CompanyExecutives__2 8,29 number_format_mio

Mr. David Denton

(59)
Pfizer Executive Vice President, Chief Financial Officer
components_CompanyExecutives__2 8,12 number_format_mio

Dr. Chris Boshoff

(61)
Pfizer Chief Scientific Officer, President - Research & Development
components_CompanyExecutives__2 7,85 number_format_mio

Mr. Douglas Lankler

(59)
Pfizer Executive Vice President, Chief Legal Officer
components_CompanyExecutives__2 5,48 number_format_mio
1
2
3
4
...
5

Pfizer components_charts_SupplyChainChart_11

components_charts_SupplyChainChart_0components_charts_SupplyChainChart_1components_charts_SupplyChainChart_2components_charts_SupplyChainChart_3components_charts_SupplyChainChart_4components_charts_SupplyChainChart_5components_charts_SupplyChainChart_6components_charts_SupplyChainChart_7
Aukett Swanke Group base_Aktie
Aukett Swanke Group
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_10 -0,31-0,550,280,260,50
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_10 0,56
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_100,61-0,09-0,290,39-0,610,17
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_100,580,820,40-0,470,14-0,56
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_100,560,810,79-0,280,600,81
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_100,560,88-0,070,48-0,71-0,65
Clovis Oncology, Inc. base_Aktie
Clovis Oncology, Inc.
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_100,550,950,700,57-0,74-0,82
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_100,540,910,240,38-0,140,57
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_100,540,590,330,250,570,63
components_charts_SupplyChainChart_9components_charts_SupplyChainChart_100,540,880,410,50-0,380,08
1
2
3
4
5
...
22

pages_aktie_[isin]__1

¿Qué valores y filosofía corporativa representa Pfizer?

Pfizer Inc representa valores de integridad, excelencia y liderazgo en la industria farmacéutica. Su filosofía corporativa se basa en la búsqueda constante de innovación y el compromiso de mejorar la salud y bienestar de las personas en todo el mundo. Pfizer tiene como objetivo proporcionar medicamentos seguros y efectivos, así como ampliar el acceso a tratamientos de calidad. Como una empresa global, Pfizer valora la diversidad, la ética empresarial y la responsabilidad social. Con una larga trayectoria en la investigación y desarrollo de medicamentos, Pfizer se enfoca en descubrir soluciones para las necesidades médicas no satisfechas, mejorando así la calidad de vida de los pacientes.

¿En qué países y regiones Pfizer está principalmente presente?

Pfizer Inc está presente principalmente en varios países y regiones alrededor del mundo. Como una compañía farmacéutica líder, Pfizer Inc opera en un amplio espectro geográfico, incluyendo América del Norte, Europa, Asia, África y América Latina. La compañía tiene una presencia significativa en Estados Unidos, donde se encuentra su sede, así como en países europeos como Reino Unido, Alemania y Francia. Pfizer también tiene una fuerte presencia en mercados emergentes como China, India y Brasil. A través de su extensa red global, Pfizer Inc se dedica a proporcionar soluciones innovadoras de atención médica en todas las áreas donde opera.

¿Qué hitos significativos ha alcanzado la empresa Pfizer?

Pfizer Inc, una empresa farmacéutica líder a nivel mundial, ha logrado varios hitos significativos a lo largo de su historia. Destaca su descubrimiento de la penicilina en la década de 1920, un antibiótico revolucionario que ha salvado innumerables vidas. También ha desarrollado medicamentos innovadores en áreas como la salud cardiovascular, el cáncer, las enfermedades infecciosas y las enfermedades neurológicas. Pfizer fue pionera en el desarrollo de la Viagra, un medicamento para la disfunción eréctil que ha sido un gran éxito comercial. Además, ha sido reconocida por su investigación en el campo de la vacunación, incluyendo la creación de la primera vacuna contra la COVID-19 en colaboración con BioNTech. Estos logros destacan el compromiso de Pfizer con la investigación científica y su contribución a mejorar la salud y el bienestar global.

¿Qué historia y antecedentes tiene la empresa Pfizer?

Pfizer Inc es una reconocida empresa farmacéutica fundada en 1849 por Charles Pfizer y Charles Erhart. Con sede en Nueva York, ha crecido hasta convertirse en una de las compañías líderes en la industria. Pfizer se dedica a la investigación, desarrollo, fabricación y venta de medicamentos y productos de salud innovadores. La empresa ha realizado importantes avances en áreas como la salud cardiovascular, oncológica, inmunología y enfermedades infecciosas. Con una amplia cartera de productos, Pfizer continúa comprometida con la búsqueda de soluciones para mejorar la calidad de vida de las personas en todo el mundo.

¿Quiénes son los principales competidores de Pfizer en el mercado?

Los principales competidores de Pfizer Inc en el mercado son Johnson & Johnson, Merck & Co., Inc. y Novartis AG. Pfizer Inc es una empresa farmacéutica líder en la industria, y se especializa en la investigación, desarrollo y comercialización de medicamentos innovadores. Con una amplia cartera de productos farmacéuticos, Pfizer compite en diversos segmentos del mercado, como cardiología, oncología, enfermedades infecciosas y más. Los competidores mencionados también son reconocidos en la industria farmacéutica por su enfoque en la innovación y el desarrollo de soluciones médicas avanzadas. Sin embargo, Pfizer Inc continúa liderando mediante su compromiso con la excelencia en la salud y el bienestar de las personas.

¿En qué industrias se dedica principalmente Pfizer?

Pfizer Inc se dedica principalmente a la industria farmacéutica. Como una de las compañías líderes a nivel mundial en este sector, Pfizer se especializa en la investigación, desarrollo, producción y comercialización de medicamentos y vacunas innovadoras. Con una extensa cartera de productos, la compañía abarca varias áreas terapéuticas como la oncología, enfermedades cardiovasculares, inmunología, neurociencia, entre otras. Pfizer se dedica a mejorar la salud y calidad de vida de las personas a través de sus productos de alta calidad y su constante inversión en investigación y desarrollo.

¿Cuál es el modelo de negocio de Pfizer?

El modelo de negocio de Pfizer Inc se basa en la investigación, desarrollo, fabricación y comercialización de productos farmacéuticos y vacunas. La compañía se dedica a descubrir y desarrollar terapias innovadoras para abordar las necesidades de salud no cubiertas en diferentes áreas, como oncología, enfermedades cardiovasculares, enfermedades infecciosas y enfermedades raras. Pfizer también se enfoca en colaboraciones estratégicas y adquisiciones para expandir su cartera de productos y tecnologías. Como una de las principales compañías farmacéuticas a nivel global, Pfizer está comprometida en mejorar la calidad de vida y brindar soluciones terapéuticas a pacientes de todo el mundo.

pages_aktie_[isin]__11

pages_aktie_[isin]__13

pages_aktie_[isin]__14

pages_aktie_[isin]__16

pages_aktie_[isin]__17

pages_aktie_[isin]__18

pages_aktie_[isin]__20

pages_aktie_[isin]__21

pages_aktie_[isin]__23

pages_aktie_[isin]__24

pages_aktie_[isin]__26

pages_aktie_[isin]__27

pages_aktie_[isin]__29

pages_aktie_[isin]__30

pages_aktie_[isin]__32

pages_aktie_[isin]__33

pages_aktie_[isin]__35

pages_aktie_[isin]__36

pages_aktie_[isin]__37

pages_aktie_[isin]__38

pages_aktie_[isin]__39

pages_aktie_[isin]__40

pages_aktie_[isin]_[key]_index_0

pages_aktie_[isin]_[key]_index_1

pages_aktie_[isin]_[key]_index_2

pages_aktie_[isin]_[key]_index_3

pages_aktie_[isin]_[key]_index_4

pages_aktie_[isin]_[key]_index_5

pages_aktie_[isin]_[key]_index_6

pages_aktie_[isin]_[key]_index_7

pages_aktie_[isin]_[key]_index_8

pages_aktie_[isin]_[key]_index_9

pages_aktie_[isin]_[key]_index_10

pages_aktie_[isin]_[key]_index_14

Wann musste ich die Aktien von Pfizer kaufen, um die vorherige Dividende zu erhalten?

pages_aktie_[isin]_[key]_index_15

pages_aktie_[isin]_[key]_index_16

pages_aktie_[isin]_[key]_index_18

pages_aktie_[isin]_[key]_index_19

pages_aktie_[isin]_[key]_index_20

pages_aktie_[isin]_[key]_index_21

pages_aktie_[isin]_[key]_index_22